Mind Medicine (MindMed) Inc.
MMED
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -630.17% | 57.08% | -45.58% | 23.65% | 79.90% |
| Total Depreciation and Amortization | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Amortization of Deferred Charges | -- | -- | -19.53% | -100.00% | -- |
| Total Other Non-Cash Items | 147.32% | -109.51% | 43.25% | -374.64% | -312.68% |
| Change in Net Operating Assets | 334.46% | -263.52% | 94.07% | 188.58% | -136.43% |
| Cash from Operations | -48.08% | -77.24% | -23.28% | -3.40% | -44.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 320.00% | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.66% | -99.44% | 47.32% | 2,244.72% | 128.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.89% | -- | -78.57% | -607.86% | -- |
| Cash from Financing | 82.15% | -99.41% | 46.82% | 298.63% | 746.78% |
| Foreign Exchange rate Adjustments | 2,400.00% | 42.86% | 104.00% | -134.38% | -98.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -437.63% | -225.07% | -19.72% | 6,386.57% | 26.48% |